Your browser doesn't support javascript.
loading
Immunological features of a lung cancer patient achieving an objective response with anti-programmed death-1 blockade therapy.
Kamata, Toshiko; Yoshida, Shigetoshi; Takami, Mariko; Ihara, Fumie; Yoshizawa, Hiroko; Toyoda, Takahide; Takeshita, Yuichiro; Nobuyama, Seiichi; Kanetsuna, Yukiko; Sato, Tetsuo; Yoshino, Ichiro; Motohashi, Shinichiro.
Afiliación
  • Kamata T; Department of Thoracic Surgery, School of Medicine, International University of Health and Welfare, Atami Hospital, Atami, Japan.
  • Yoshida S; Department of Medical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Takami M; Department of Thoracic Surgery, School of Medicine, International University of Health and Welfare, Atami Hospital, Atami, Japan.
  • Ihara F; Department of Medical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Yoshizawa H; Department of Medical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Toyoda T; Department of Medical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Takeshita Y; Department of Medical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Nobuyama S; Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Kanetsuna Y; Department of Respirology, Atami Hospital, International University of Health and Welfare, Atami, Japan.
  • Sato T; Department of Respirology, Atami Hospital, International University of Health and Welfare, Atami, Japan.
  • Yoshino I; Department of Clinical Pathology, Atami Hospital, International University of Health and Welfare, Atami, Japan.
  • Motohashi S; Department of Respirology, Atami Hospital, International University of Health and Welfare, Atami, Japan.
Cancer Sci ; 111(1): 288-296, 2020 Jan.
Article en En | MEDLINE | ID: mdl-31677359
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Neoplasias Pulmonares / Anticuerpos Monoclonales Límite: Aged / Humans / Male Idioma: En Revista: Cancer Sci Año: 2020 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Neoplasias Pulmonares / Anticuerpos Monoclonales Límite: Aged / Humans / Male Idioma: En Revista: Cancer Sci Año: 2020 Tipo del documento: Article País de afiliación: Japón